OBJECTIVE: To identify and characterize cup to disc ratio (CDR) and related optic nerve head abnormalities in multiple sclerosis (MS) using spectral domain optical coherence tomography (OCT). BACKGROUND: While CDR is routinely assessed by ophthalmologists in the evaluation of glaucoma, CDR and related optic nerve head metrics remain largely unexplored in MS. DESIGN/ METHODS: Cirrus-HD (high density) OCT was used to evaluate average CDR, vertical CDR, optic disc area, optic cup volume, and neuro-retinal rim area in 105 MS patients and 88 age-matched healthy individuals. High-contrast (100%) visual acuity, 2.5% low-contrast letter acuity and 1.25% low-contrast letter acuity were assessed in 77 MS patients. Two-sample t-tests were used in the analysis of OCT-derived optic nerve head measures between healthy controls and MS patients. Multivariate regression (accounting for age and gender) was used to assess relationships between optic nerve head measures and visual function. RESULTS: Average CDR (p=0.007) and vertical CDR (p=0.005) were greater in MS patients compared to healthy controls, while neuro-retinal rim area was decreased in MS patients (p=0.001). CDR increased with retinal nerve fiber layer (RNFL) thinning (r=-0.29, p=0.001). 2.5% low-contrast (p=0.005) and 1.25% low-contrast letter acuity (p=0.03) were lower in MS patients with higher vertical CDR. CONCLUSIONS/RELEVANCE: CDR (as determined by spectral domain OCT) is abnormal in MS and correlates with visual function. OCT-derived CDR and related optic nerve head metrics may represent an objective measure by which to monitor disease progression, and potentially neuroprotection, in therapeutic MS trials.
OBJECTIVE: To identify and characterize cup to disc ratio (CDR) and related optic nerve head abnormalities in multiple sclerosis (MS) using spectral domain optical coherence tomography (OCT). BACKGROUND: While CDR is routinely assessed by ophthalmologists in the evaluation of glaucoma, CDR and related optic nerve head metrics remain largely unexplored in MS. DESIGN/ METHODS:Cirrus-HD (high density) OCT was used to evaluate average CDR, vertical CDR, optic disc area, optic cup volume, and neuro-retinal rim area in 105 MSpatients and 88 age-matched healthy individuals. High-contrast (100%) visual acuity, 2.5% low-contrast letter acuity and 1.25% low-contrast letter acuity were assessed in 77 MSpatients. Two-sample t-tests were used in the analysis of OCT-derived optic nerve head measures between healthy controls and MSpatients. Multivariate regression (accounting for age and gender) was used to assess relationships between optic nerve head measures and visual function. RESULTS: Average CDR (p=0.007) and vertical CDR (p=0.005) were greater in MSpatients compared to healthy controls, while neuro-retinal rim area was decreased in MSpatients (p=0.001). CDR increased with retinal nerve fiber layer (RNFL) thinning (r=-0.29, p=0.001). 2.5% low-contrast (p=0.005) and 1.25% low-contrast letter acuity (p=0.03) were lower in MSpatients with higher vertical CDR. CONCLUSIONS/RELEVANCE: CDR (as determined by spectral domain OCT) is abnormal in MS and correlates with visual function. OCT-derived CDR and related optic nerve head metrics may represent an objective measure by which to monitor disease progression, and potentially neuroprotection, in therapeutic MS trials.
Authors: Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary Cutter; Laura J Balcer Journal: Nat Clin Pract Neurol Date: 2008-12
Authors: K W Chung; S B Kim; K D Park; K G Choi; J H Lee; H W Eun; J S Suh; J H Hwang; W K Kim; B C Seo; S H Kim; I H Son; S M Kim; I N Sunwoo; B O Choi Journal: Brain Date: 2006-07-10 Impact factor: 13.501
Authors: Fiona Costello; Stuart Coupland; William Hodge; Gianni R Lorello; Jeannie Koroluk; Y Irene Pan; Mark S Freedman; David H Zackon; Randy H Kardon Journal: Ann Neurol Date: 2006-06 Impact factor: 10.422
Authors: J Toledo; J Sepulcre; A Salinas-Alaman; A García-Layana; M Murie-Fernandez; B Bejarano; P Villoslada Journal: Mult Scler Date: 2008-06-23 Impact factor: 6.312
Authors: G Rebolleda; S Noval; I Contreras; F Arnalich-Montiel; J L García-Perez; F J Muñoz-Negrete Journal: Eye (Lond) Date: 2008-04-25 Impact factor: 3.775
Authors: E Gordon-Lipkin; B Chodkowski; D S Reich; S A Smith; M Pulicken; L J Balcer; E M Frohman; G Cutter; P A Calabresi Journal: Neurology Date: 2007-10-16 Impact factor: 9.910
Authors: Kay Gawlik; Frank Hausser; Friedemann Paul; Alexander U Brandt; Ella Maria Kadas Journal: Biomed Opt Express Date: 2018-11-28 Impact factor: 3.732
Authors: Laura J Balcer; Jenelle Raynowska; Rachel Nolan; Steven L Galetta; Raju Kapoor; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn Hudson; Richard Rudick Journal: Mult Scler Date: 2017-02-16 Impact factor: 6.312
Authors: Leandro B C Teixeira; James N Ver Hoeve; Joshua A Mayer; Richard R Dubielzig; Chelsey M Smith; Abigail B Radcliff; Ian D Duncan Journal: Invest Ophthalmol Vis Sci Date: 2016-09-01 Impact factor: 4.799
Authors: Drew R Nannini; Mina Torres; Yii-Der I Chen; Kent D Taylor; Jerome I Rotter; Rohit Varma; Xiaoyi Gao Journal: Invest Ophthalmol Vis Sci Date: 2017-01-01 Impact factor: 4.925